An Impressive Approach in Nuclear Medicine: Theranostics

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

An Impressive Approach in Nuclear Medicine: Theranostics Publisher Pubmed

Vahidfar N¹ ; Eppard E^{2, 3} ; Farzanehfar S¹ ; Yordanova A⁴ ; Fallahpoor M¹ ; Ahmadzadehfar H⁵

Show Affiliations

1. Department of Nuclear Medicine, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
2. Positronpharma SA, Santiago, Chile
3. Department of Nuclear Medicine, University Hospital Magdeburg, Germany
4. Department of Radiology, Marienhospital Bonn, Bonn
5. Department of Nuclear Medicine, Klinikum Westfalen, Dortmund, Germany

Source: PET Clinics Published:2021

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. Theranostic Advances in Breast Cancer in Nuclear Medicine, International Journal of Molecular Sciences (2021)

2. Historical Review of Pharmacological Development and Dosimetry of Psma-Based Theranostics for Prostate Cancer, Journal of Radioanalytical and Nuclear Chemistry (2019)

3. Targeted Palliative Radionuclide Therapy for Metastatic Bone Pain, Journal of Clinical Medicine (2020)

4. 68Ga-Fapi, a Twin Tracer for 18F-Fdg in the Era of Evolving Pet Imaging, Radiology-Nuclear Medicine Diagnostic Imaging: A Correlative Approach (2023)

5. Targeted Radioligand Therapy: Physics and Biology, Internal Dosimetry and Other Practical Aspects During 177Lu/225Ac Treatment in Neuroendocrine Tumors and Metastatic Prostate Cancer, Theranostics (2025)

6. Recent Clinical Implications of Fapi Imaging and Therapy, Clinical Nuclear Medicine (2024)

7. The Prognostic and Therapeutic Value and Clinical Implications of Fibroblast Activation Protein-Α As a Novel Biomarker in Colorectal Cancer, Cell Communication and Signaling (2023)

8. Evaluation of 153Sm/177Lu-Edtmp Mixture in Wild-Type Rodents As a Novel Combined Palliative Treatment of Bone Pain Agent, Journal of Radioanalytical and Nuclear Chemistry (2015)

Experts (# of related papers)

View all Related Experts

Davood Beiki (6)

Reyhaneh Manafi-Farid (5)

Other Related Docs

9. Production, Quality Control, Biodistribution Assessment and Preliminary Dose Evaluation of 166Ho-Alendronate As a Bone Marrow Ablative Agent, Radiochimica Acta (2015)

10. 177Lu-Edtmp for Metastatic Bone Pain Palliation: A Systematic Review and Meta-Analysis, Cancer Biotherapy and Radiopharmaceuticals (2021)

11. Development of 166Ho-Pamidronate for Bone Pain Palliation Therapy, Journal of Radioanalytical and Nuclear Chemistry (2015)

12. Production and Clinical Applications of Radiopharmaceuticals and Medical Radioisotopes in Iran, Seminars in Nuclear Medicine (2016)

13. Development of 153Sm/177Lu-Edtmp As a Possible Therapeutic Complex, Iranian Journal of Nuclear Medicine (2017)

14. Production of the State of the Art Therapeutic Radiopharmaceuticals in Iran, From Beta- to Alpha-Emitting Targeted Radionuclide Therapy: Clinical Advances and Perspectives, Iranian Journal of Nuclear Medicine (2024)

15. Bone Metastasis in Prostate Cancer: Bone Scan Versus Pet Imaging, Seminars in Nuclear Medicine (2024)

16. The Iranian Society of Nuclear Medicine Practical Guideline on Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Using 177Lu-Psma, Iranian Journal of Nuclear Medicine (2018)

17. Factors Predicting Biochemical Response and Survival Benefits Following Radioligand Therapy With [177Lu]Lu-Psma in Metastatic Castrate-Resistant Prostate Cancer: A Review, European Journal of Nuclear Medicine and Molecular Imaging (2021)

18. Design, Synthesis, Radiolabeling and Biological Evaluation of New Urea-Based Peptides Targeting Prostate Specific Membrane Antigen, Bioorganic Chemistry (2020)

19. Automated Segmentation of Lesions and Organs at Risk on [68Ga]Ga-Psma-11 Pet/Ct Images Using Self-Supervised Learning With Swin Unetr, Cancer Imaging (2024)

20. Superscan Pattern on Bone Scintigraphy: A Comprehensive Review, Diagnostics (2024)

21. Impact of Tsh Stimulation on 2-[18F]Fdg Pet/Ct Results in Patients With Papillary Thyroid Carcinoma Presented With Elevated Serum Thyroglobulin Level and Negative Diagnostic Iodine-131 Whole-Body Scan, Iranian Journal of Nuclear Medicine (2022)

22. Indications for Diagnostic Whole-Body Iodine Scan: A Review of Guidelines, Nuclear Medicine Communications (2024)

Style	Citing Format
MLA	Vahidfar N, et al.. "An Impressive Approach in Nuclear Medicine: Theranostics." PET Clinics, vol. 16, no. 3, 2021, pp. 327-340.
APA	Vahidfar N, Eppard E, Farzanehfar S, Yordanova A, Fallahpoor M, Ahmadzadehfar H (2021). An Impressive Approach in Nuclear Medicine: Theranostics. PET Clinics, 16(3), 327-340.
Chicago	Vahidfar N, Eppard E, Farzanehfar S, Yordanova A, Fallahpoor M, Ahmadzadehfar H. "An Impressive Approach in Nuclear Medicine: Theranostics." PET Clinics 16, no. 3 (2021): 327-340.
Harvard	Vahidfar N et al. (2021) 'An Impressive Approach in Nuclear Medicine: Theranostics', PET Clinics, 16(3), pp. 327-340.
Vancouver	Vahidfar N, Eppard E, Farzanehfar S, Yordanova A, Fallahpoor M, Ahmadzadehfar H. An Impressive Approach in Nuclear Medicine: Theranostics. PET Clinics. 2021;16(3):327-340.
BibTex	@article{ author = {Vahidfar N and Eppard E and Farzanehfar S and Yordanova A and Fallahpoor M and Ahmadzadehfar H}, title = {An Impressive Approach in Nuclear Medicine: Theranostics}, journal = {PET Clinics}, volume = {16}, number = {3}, pages = {327-340}, year = {2021} }
RIS	TY - JOUR AU - Vahidfar N AU - Eppard E AU - Farzanehfar S AU - Yordanova A AU - Fallahpoor M AU - Ahmadzadehfar H TI - An Impressive Approach in Nuclear Medicine: Theranostics JO - PET Clinics VL - 16 IS - 3 SP - 327 EP - 340 PY - 2021 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract